Home›Companies›Biotech & Pharma›Cytovia

Cytovia, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 26, 2023·Suggest an edit

About Cytovia

Cytovia is a private company based in Aventura, Florida, incorporated in 2022 in Delaware. It has reported $11,545,000 raised in three offerings on Form D since July 2022. Its chief executive is Daniel Teper.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 11, 2023Jan 26, 2023$1,195,000of $5.0M target10$119KEquity, Debt, OptionsRule 506(b)Form D ↗
May 25, 2022Jul 18, 2022$7,825,000of $10.0M target14$558KDebt, OptionsRule 506(b)Form D ↗
Mar 18, 2022Jul 18, 2022$2,525,000of $15.0M target9$280KDebt, OptionsRule 506(b)Form D ↗
Total, three offerings$11,545,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cytovia's Form D filed Jan 26, 2023.

DT
Daniel Teper
Chief Executive Officer & Director
AR
Armin Rath
Head of New Product Development
WL
Wei Li
Chief Scientific Officer
MN
Michael Noonan
Chief Financial Officer
GF
GS

Earlier filings also listed Thomas Robinson (director, last listed Jul 2022), Stanley Frankel (executive officer, last listed Jul 2022), Michael Friedman (director, last listed Jul 2022), Luca Scavo (executive officer, last listed Jul 2022), Laurent Audoly (director, last listed Jul 2022) and Jason Aryeh (director, last listed Jul 2022).

Sources

  1. SECCytovia, Inc. filing history